Description     Claims     Drawing  

WO2006046923A   [0007] 
WO9110425A   [0091] 

Remington: The Science and Practice of Pharmacy   [0090] 
Encyclopedia of Pharmaceutical Technology   [0090] 
Insulin production by human embryonic stem cells   [0138] 
Transdifferentiation of pancreatic ductal cells to endocrine beta-cells   [0138] 
Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules   [0138] 
Label-retaining cells in the rat pancreas: location and differentiation potential in vitro   [0138] 
The mesenchyme controls the timing of pancreatic beta-cell differentiation   [0138] 
Transplantation of insulin-producing clusters derived from adult bone marrow stem cells to treat diabetes in rats.   [0138] 
neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas.   [0138] 
Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors   [0138] 
Glucose is necessary for embryonic pancreatic endocrine cell differentiation   [0138] 
The role of Brn4/Pou3f4 and Pax6 in forming the pancreatic glucagon cell identity   [0138] 
Differentiation of insulin-producing cells from human neural progenitor cells   [0138] 
Regulation of the pancreatic islet-specific gene BETA2 (neuroD) by neurogenin   [0138] 
The cystic fibrosis transmembrane conductance regulator as a marker of human pancreatic duct development   [0138] 
Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation   [0138] 
Osteopontin is a novel marker of pancreatic ductal tissues and of undifferentiated pancreatic precursors in mice   [0138] 
Islet regeneration during the reversal of autoimmune diabetes in NOD mice   [0138] 
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method   [0138] 
Generation of human induced pluripotent stem cells from dermal fibroblasts   [0138] 
Guidelines and techniques for the generation of induced pluripotent stem cells   [0138] 
MafA regulates expression of genes important to islet beta-cell function.   [0138] 
Follistatin regulates the relative proportions of endocrine versus exocrine tissue during pancreatic development   [0138] 
Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro   [0138] 
Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes.   [0138] 
IPF1, a homeodomain-containing transactivator of the insulin gene   [0138] 
Establishment of human embryonic stem cell lines from frozen-thawed blastocysts using STO cell feeder layers.   [0138] 
Encapsulation of human islets in novel inhomogeneous alginate-ca2+/ba2+ microbeads: in vitro and in vivo function   [0138] 
Artificial reprogramming of human somatic cells to generate pluripotent stem cells: A possible alternative to the controversial use of human embryonic stem cells   [0138] 
Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells   [0138] 
Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages   [0138] 
Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro   [0138] 
Induction of pluripotent stem cells from adult human fibroblasts by defined factors   [0138] 
Generation of insulinsecreting islet-like clusters from human skin fibroblasts   [0138] 
Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells   [0138] 
In vitro transdifferentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells   [0138] 
Induced pluripotent stem cell lines derived from human somatic cells   [0138] 
MafA is a key regulator of glucose-stimulated insulin secretion   [0138]